John Libbey Eurotext

European Cytokine Network

TGF-β1 functional polymorphisms: a review Volume 27, numéro 4, October-November-December 2016

  • [1] Chin D., Boyle G.M., Parsons P.G., Coman W.B. What is transforming growth factor-beta (TGF-B)? Br J Plast Surg. 2004;57:215-221.
  • [2] Kubiczkova L., Sedlarikova L., Hajek R., Sevcikova S. TGF-beta - an excellent servant but a bad master. J Transl Med. 2012;10:183.
  • [3] Dela Cruz C., Reis F.M. The role of TGFβ superfamily members in the pathophysiology of endometriosis. Gynecol Endocrinol. 2015;31:511-515.
  • [4] Kehrl J.H., Wakefield L.M., Roberts A.B. Production of transforming growth factor beta by human T lymphocytes and its potential role in the regulation of T cell growth. J Exp Med. 1986;163:1037-1050.
  • [5] Ge Y.Z., Wu R., Lu T.Z. Combined effects of TGF-β1 +869 T/C and +915 G/C polymorphisms on acute rejection risk in solid organ transplant recipients: a systematic review and meta-analysis. PLoS One. 2014;9:1-9.
  • [6] Massagué J., Gomis R.R. The logic of TGFβ signaling. FEBS Lett. 2006;580:2811-2820.
  • [7] ten Dijke P. Signaling inputs converge on nuclear effectors in TGF-β signaling. Trends Biochem Sci. 2000;25:64-70.
  • [8] Gressner A.M., Weiskirchen R., Breitkopf K., Dooley S. Roles of TGF-beta in hepatic fibrosis. Front Biosci. 2002;7:d793-807.
  • [9] Hutchinson I.V. The role of transforming growth factor-beta in transplant rejection. Transplant Proc. 1999;31:9S-13S.
  • [10] Derynck R., Akhurst R.J., Balmain A. TGF-β signaling in tumor suppression and cancer progression. Nat Genet. 2001;29:117-129.
  • [11] Xiao Y.Q., Freire-de-Lima C.G., Schiemann W.P., Bratton D.L., Vandivier R.W., Henson P.M. Transcriptional and translational regulation of TGF-beta production in response to apoptotic cells. J Immunol. 2008;181:3575-3585.
  • [12] Gentry L.E., Nash B.W. The pro domain of pre-pro-transforming growth factor beta 1 when independently expressed is a functional binding protein for the mature growth factor. Biochemistry. 1990;29:6851-6857.
  • [13] Poniatowski ŁA, Wojdasiewicz P., Gasik R., Szukiewicz D. Transforming growth factor beta family: insight into the role of growth factors in regulation of fracture healing biology and potential clinical applications. Mediators Inflamm. 2015;2015:137823.
  • [14] Gentry L.E., Lioubin M.N., Purchio F., Marquardt H. Molecular events in the processing of recombinant type 1 pre-pro-transforming growth factor beta to the mature polypeptide. Mol Cell Biol. 1988;8:4162-4168.
  • [15] ten Dijke P., Arthur H.M. Extracellular control of TGF-beta signalling in vascular development and disease. Nat Rev Mol Cell Biol. 2007;8:857-869.
  • [16] Kusakabe M., Cheong P.L., Nikfar R., McLennan I.S., Koishi K. The structure of the TGF-β latency associated peptide region determines the ability of the proprotein convertase furin to cleave TGF-βs. J Cell Biochem. 2008;103:311-320.
  • [17] Kanzaki T., Olofsson A., Morén A. TGF-beta 1 binding protein: a component of the large latent complex of TGF-beta 1 with multiple repeat sequences. Cell. 1990;61:1051-1061.
  • [18] Saharinen J., Taipale J., Keski-Oja J. Association of the small latent transforming growth factor-beta with an eight cysteine repeat of its binding protein LTBP-1. EMBO J. 1996;15:245-253.
  • [19] Papageorgis P. TGF-β signaling in tumor initiation, epithelial-to-mesenchymal transition, and metastasis. J Oncol. 2015;2015:587193.
  • [20] Piek E., Heldin C.H., Ten Dijke P. Specificity, diversity, and regulation in TGF-beta superfamily signaling. FASEB J. 1999;13:2105-2124.
  • [21] Lyons R.M., Keski-Oja J., Moses H.L. Proteolytic activation of latent transforming growth factor-beta from fibroblast-conditioned medium. J Cell Biol. 1988;106:1659-1665.
  • [22] Barcellos-Hoff M.H., Derynck R., Tsang M.L., Weatherbee J.A. Transforming growth factor-beta activation in irradiated murine mammary gland. J Clin Invest. 1994;93:892-899.
  • [23] Derynck R., Rhee L., Chen E.Y., Van Tilburg A. Intron-exon structure of the human transforming growth factor-beta precursor gene. Mol Gen Genet. 1987;15:3188-3189.
  • [24] Thys M., Schrauwen I., Vanderstraeten K. The coding polymorphism T263I in TGF-B1 is associated with otosclerosis in two independent populations. Hum Mol Genet. 2007;16:2021-2030.
  • [25] Cambien F., Ricard S., Troesch A. Polymorphisms of the transforming growth factor-beta 1 gene in relation to myocardial infarction and blood pressure. Hypertension. 1996;28:881-887.
  • [26] Shah R., Rahaman B., Hurley C.K., Posch P.E. Allelic diversity in the TGF-β1 regulatory region: characterization of novel functional single nucleotide polymorphisms. Hum Genet. 2006;119:61-74.
  • [27] Kim S.J., Glick A., Sporn M.B., Roberts A.B. Characterization of the promoter region of the human transforming growth factor-beta 1 gene. J Biol Chem. 1989;264:402-408.
  • [28] Dhaouadi N., Li J.Y., Feugier P. Computational identification of potential transcriptional regulators of TGF-B1 in human atherosclerotic arteries. Genomics. 2014;103:357-370.
  • [29] Baugé C., Cauvard O., Leclercq S., Galéra P., Boumédiene K. Modulation of transforming growth factor beta signalling pathway genes by transforming growth factor beta in human osteoarthritic chondrocytes: involvement of Sp1 in both early and late response cells to transforming growth factor beta. Arthritis Res Ther. 2011;13:R23.
  • [30] Birchenall-Roberts M.C., Ruscetti F.W., Kasper J. Transcriptional regulation of the transforming growth factor b1 promotor by v-src gene products is mediated through the AP-1 complex. Mol Cell Biol. 1990;10:4978-4983.
  • [31] Buck A., Ellenrieder V. Recent advances in TGFβ-regulated transcription during carcinogenesis. Signal Transduct. 2006;6:345-354.
  • [32] Ogata H., Chinen T., Yoshida T. Loss of SOCS3 in the liver promotes fibrosis by enhancing STAT3-mediated TGF-beta1 production. Oncogene. 2006;25:2520-2530.
  • [33] Kim SJ, Yoo YDO, Chiou C, Choi KS, Yi Y. The IE2 regulatory protein of human cytomegalovirus induces expression of the human transforming growth factor beta1 gene through an Egr-1 binding site. J Virol 1996;70:7062-70.
  • [34] Weigert C., Sauer U., Brodbeck K., Pfeiffer A., Häring H.U., Schleicher E. AP-1 proteins mediate hyperglycemia-induced activation of the human TGF-beta1 promoter in mesangial cells. J Am Soc Nephrol. 2000;11:2007-2016.
  • [35] Presser L.D., McRae S., Waris G. Activation of TGF-B1 promoter by hepatitis C virus-induced AP-1 and Sp1: role of TGF-B1 in hepatic stellate cell activation and invasion. PLoS One. 2013;8:e56367.
  • [36] Dey B.R., Sukhatme V.P., Roberts A.B. Repression of the transforming growth factor-beta 1 gene by the Wilms’ tumor suppressor WT1 gene product. Mol Endocrinol. 1994;8:595-602.
  • [37] Karki R., Pandya D., Elston R.C., Ferlini C. Defining “mutation” and “polymorphism” in the era of personal genomics. BMC Med Genomics. 2015;8:37.
  • [38] Brookes A.J. The essence of SNPs. Gene. 1999;234:177-186.
  • [39] Aerts J., Wetzels Y., Cohen N., Aerssens J. Data mining of public SNP databases for the selection of intragenic SNPs. Hum Mutat. 2002;20:162-173.
  • [40] Shastry B.S. SNPs: impact on gene function and phenotype. Methods Mol Biol. 2009;578:3-22.
  • [41] Grainger D.J., Heathcote K., Chiano M. Genetic control of the circulating concentration of transforming growth factor type beta1. Hum Mol Genet. 1999;8:93-97.
  • [42] Syrris P., Carter N.D., Metcalfe J.C. Transforming growth factor-beta1 gene polymorphisms and coronary artery disease. Clin Sci. 1998;95:659-667.
  • [43] Jin Q., Hemminki K., Grzybowska E. Polymorphisms and haplotype structures in genes for transforming growth factor B1 and its receptors in familial and unselected breast cancers. Int J Cancer. 2004;112:94-99.
  • [44] Shah R., Hurley C.K., Posch P.E. A molecular mechanism for the differential regulation of TGF-B1 expression due to the common SNP - 509C-T (c -1347C > T). Hum Genet. 2006;120:461-469.
  • [45] Guo W., Dong Z., Guo Y. Polymorphisms of transforming growth factor-β1 associated with increased risk of gastric cardia adenocarcinoma in north China. PLoS One. 2014;9:e112912.
  • [46] Cao H., Zhou Q., Lan R. A functional polymorphism C-509T in TGF-β-1 promoter contributes to susceptibility and prognosis of lone atrial fibrillation in chinese population. Int J Immunogenet. 2011;38:215-224.
  • [47] Luedecking E.K., DeKosky S.T., Mehdi H., Ganguli M., Kamboh M.I. Analysis of genetic polymorphisms in the transforming growth factor-beta1 gene and the risk of Alzheimer's disease. Hum Genet. 2000;106:565-569.
  • [48] Silverman E.S., Palmer L.J., Subramaniam V. Transforming growth factor-β 1 promoter polymorphism C-509T is associated with asthma. Am J Respir Crit Care Med. 2004;169:214-219.
  • [49] Randall L.L., Hardy S.J. Unity in function in the absence of consensus in sequence: role of leader peptides in export. Science. 1989;243:1156-1159.
  • [50] Dunning A.M., Ellis P.D., McBride S. A transforming growth factor beta1 signal peptide variant increases secretion in vitro and is associated with increased incidence of invasive breast cancer. Cancer Res. 2003;63:2610-2615.
  • [51] Pooja S., Francis A., Rajender S. Strong impact of TGF-β1 gene polymorphisms on breast cancer risk in Indian women: a case-control and population-based study. PLoS One. 2013;8:e75979.
  • [52] Taubenschuss E., Marton E., Mogg M. The L10P polymorphism and serum levels of transforming growth factor beta1 in human breast cancer. Int J Mol Sci. 2013;14:15376-15385.
  • [53] Yokota M., Ichihara S., Lin T.-L., Nakashima N., Yamada Y. Association of a T29>C polymorphism of the transforming growth factor-B1 gene with genetic susceptibility to myocardial infarction in Japanese. Circulation. 2000;101:2783-2787.
  • [54] Awad M.R., El-Gamel A., Hasleton P., Turner D.M., Sinnott P.J., Hutchinson I.V. Genotypic variation in the transforming growth factor-beta1 gene: association with transforming growth factor-beta1 production, fibrotic lung disease, and graft fibrosis after lung transplantation. Transplantation. 1998;66:1014-1020.
  • [55] Nel M., Buys J.-M., Rautenbach R., Mowla S., Prince S., Heckmann J.M. The African−387 C>T TGF-β1 variant is functional and associates with the ophthalmoplegic complication in juvenile myasthenia gravis. J Hum Genet. 2016;61:307-316.
  • [56] Janssens K., Gershoni-Baruch R., Guañabens N. Mutations in the gene encoding the latency-associated peptide of TGF-β1 cause Camurati-Engelmann disease. Nature. 2000;417:708.
  • [57] Park B.L., Han I.K., Lee H.S., Kim L.H., Kim S.J., Shin H.D. Identification of novel variants in transforming growth factor-beta 1 (TGF-β1) gene and association analysis with bone mineral density. Hum Mutat. 2003;22:257-258.
  • [58] Healy J., Dionne J., Belanger H. Functional impact of sequence variation in the promoter region of TGF-β1. Int J Cancer. 2009;125:1483-1489.
  • [59] Knight JC, Keating BJ, Kwiatkowski DP. Allele-specific repression of lymphotoxin- α by activated B cell factor-1. Nature Genetics 2004;36:394-9.
  • [60] Crawford D.C., Nickerson D.A. Definition and clinical importance of haplotypes. Annu Rev Med. 2005;56:303-320.
  • [61] Ramos-Flores C., Romero-Gutierrez T., Delgado-Enciso I. Polymorphisms in the genes related to angiogenesis are associated with uterine cervical cancer. Int J Gynecol Cancer. 2013;23:1198-1204.
  • [62] Xu J., Yu X., Huang C. Association of 5 Well-Defined Polymorphisms in the Gene Encoding Transforming Growth Factor- 1 With Coronary Artery Disease Among Chinese Patients With Hypertension. Angiology. 2014;66:1-7.
  • [63] Liu Y., Lin X.-F., Lin C.-J., Jin S.-S., Wu J.-M. Transforming growth factor beta-1 C-509T polymorphism and cancer risk: a meta-analysis of 55 case-control studies. Asian Pac J Cancer Prev. 2012;13:4683-4688.
  • [64] Slattery M.L., Herrick J.S., Lundgreen A., Wolff R.K. Genetic variation in the TGF-β signaling pathway and colon and rectal cancer risk. Cancer Epidemiol Biomarkers Prev. 2011;20:57-69.
  • [65] Jin G., Deng Y., Miao R. TGF-β1 and TGF-β2 functional polymorphisms and risk of esophageal squamous cell carcinoma: a case-control analysis in a Chinese population. J Cancer Res Clin Oncol. 2008;134:345-351.
  • [66] Wei Y.S., Xu Q.Q., Wang C.F., Pan Y., Liang F., Long X.K. Genetic variation in transforming growth factor-beta1 gene associated with increased risk of esophageal squamous cell carcinoma. Tissue Antigens. 2007;70:464-469.
  • [67] Wei Y.-S., Zhu Y.-H., Du B. Association of transforming growth factor-beta1 gene polymorphisms with genetic susceptibility to nasopharyngeal carcinoma. Clin Chim Acta. 2007;380:165-169.
  • [68] Hu S., Zhou G., Zhang L., Jiang H., Xiao M. The effects of functional polymorphisms in the TGFβ1 gene on nasopharyngeal carcinoma susceptibility. Otolaryngol Head Neck Surg. 2012;146:579-584.
  • [69] Ewart-Toland A., Chan J.M., Yuan J., Balmain A., Ma J. A gain of function TGF-β1 polymorphism may be associated with late stage prostate cancer. Cancer Epidemiol Biomarkers Prev. 2004;13:759-764.
  • [70] Chang W., Zhang L., Su H., Yao Y. An updated meta-analysis of transforming growth factor-β1 gene: three polymorphisms with gastric cancer. Tumour Biol. 2014;35:2837-2844.
  • [71] Jin G., Wang L., Chen W. Variant alleles of TGF-β1 and TGF-β2 are associated with a decreased risk of gastric cancer in a Chinese population. Int J Cancer. 2007;120:1330-1335.
  • [72] Xu L., Zeng Z., Chen B. Association between the TGF-β1-509C/T and TGF-βR2-875A/G polymorphisms and gastric cancer: a case-control study. Oncol Lett. 2011;2:371-377.
  • [73] Singh H., Jain M., Mittal B. Role of TGF-beta1 (-509C>T) promoter polymorphism in susceptibility to cervical cancer. Oncol Res. 2009;18:41-45.
  • [74] Torres-Poveda K., Burguete-García A.I., Bahena-Román M. Risk allelic load in Th2 and Th3 cytokines genes as biomarker of susceptibility to HPV-16 positive cervical cancer: a case control study. BMC Cancer. 2016;16:330.
  • [75] Lu Y., Boer J.M.A., Barsova R.M. TGF-β1 genetic polymorphisms and coronary heart disease risk: a meta-analysis. BMC Med Genet. 2012;13:39.
  • [76] Morris D.R., Moxon J.V., Biros E., Krishna S.M., Golledge J. Meta-analysis of the association between transforming growth factor-beta polymorphisms and complications of coronary heart disease. PLoS One. 2012;7:e37878.
  • [77] Langdahl B.L., Uitterlinden A.G., Ralston S.H. Large-scale analysis of association between polymorphisms in the transforming growth factor beta 1 gene (TGF-β1) and osteoporosis: the GENOMOS study. Bone. 2008;42:969-981.
  • [78] Sie M.P.S., Uitterlinden A.G., Bos M.J. TGF-β1 polymorphisms and risk of myocardial infarction and stroke: the Rotterdam study. Stroke. 2006;37:2667-2671.
  • [79] Cui L, Sun Y, Li D, Wang S, Shao D. Transforming growth factor-β1 rs1800469 polymorphism and periodontitis risk: a meta-analysis. Int J Clin Exp Med 2015 ; 8 : 15569-74.
  • [80] Celedón J.C., Lange C., Raby B. The transforming growth factor-beta1 (TGF-β1) gene is associated with chronic obstructive pulmonary disease (COPD). Hum Mol Genet. 2004;13:1649-1656.
  • [81] Wang HB, Song WG, Liu HQ, Fang F, Xiao Y. Role of TGF-β1 polymorphism in the development of metastatic brain tumors in non-small cell lung cancer patients. Genet Mol Res 2015 ; 14 : 1-2.
  • [82] Vuong M.T., Lundberg S., Gunnarsson I. Genetic variation in the transforming growth factor- 1 gene is associated with susceptibility to IgA nephropathy. Nephrol Dial Transplant. 2009;24:3061-3067.
  • [83] Barsova R.M., Titov B.V., Matveeva N.A. Contribution of the TGF-β1 Gene to Myocardial Infarction Susceptibility. Acta Naturae. 2012;4:74-79.
  • [84] Heidari Z., Mahmoudzadeh Sagheb H., Sheibak N. Association between TGF-Beta1 (-509) C/T gene polymorphism and tissue degradation level in chronic periodontitis: a stereological study. Gene Cell Tissue. 2015;2:1-7.
  • [85] Zhang L., Mao L., Xu J. Transforming growth factor-β1 polymorphisms and graft-versus-host disease risk: a meta-analysis. Oncotarget. 2015;7:2455-2461.
  • [86] Tao H., Chen G., Cheng G., Shan X. The haplotype of the TGFβ1 gene associated with cerebral infarction in Chinese. Can J Neurol Sci. 2012;39:626-631.
  • [87] Peng Z., Zhan L., Chen S., Xu E. Association of transforming growth factor-β1 gene C-509T and T869C polymorphisms with atherosclerotic cerebral infarction in the Chinese: a case-control study. Lipids Health Dis. 2011;10:100.
  • [88] Li X, Zong Q, Han F. Associations between transforming growth factor-β1 gene -509C/T and + 915G/C polymorphisms and pneumoconiosis: a meta-analysis. Int J Clin Exp Med 2016 ; 9 : 5764-72.
  • [89] Jonth A.C., Silveira L., Fingerlin T.E. TGF-1 variants in chronic beryllium disease and sarcoidosis. J Immunol. 2007;179:4255-4262.
  • [90] Carneiro N.K., Oda J.M.M., Losi Guembarovski R. Possible association between TGF-β1 polymorphism and oral cancer. Int J Immunogenet. 2013;40:292-298.
  • [91] Shin A., Shu X.-O., Cai Q., Gao Y.-T., Zheng W. Genetic polymorphisms of the transforming growth factor-beta1 gene and breast cancer risk: a possible dual role at different cancer stages. Cancer Epidemiol Biomarkers Prev. 2005;14:1567-1570.
  • [92] Ziv E., Cauley J., Morin P.A., Saiz R., Browner W.S. Association between the T29>C polymorphism in the transforming growth factor beta1 gene and breast cancer among elderly white women: the Study of Osteoporotic Fractures. JAMA. 2001;285:2859-2863.
  • [93] Guan X., Sturgis E.M., Lei D. Association of TGF-beta1 genetic variants with HPV16-positive oropharyngeal cancer. Clin Cancer Res. 2010;16:1416-1422.
  • [94] Li Z., Habuchi T., Tsuchiya N. Increased risk of prostate cancer and benign prostatic hyperplasia associated with transforming growth factor-beta 1 gene polymorphism at codon10. Carcinogenesis. 2004;25:237-240.
  • [95] Fan H., Yu H., Deng H., Chen X. Transforming growth factor-β1 rs1800470 polymorphism is associated with lung cancer risk: a meta-analysis. Med Sci Monit. 2014;20:2358-2362.
  • [96] Sandhya A., Bindu C.H., Reddy K.P., Vishnupriya S. TGF-β1 codon 10 polymorphism and its association with the development of myopia: a case-control study. Biol Med. 2011;3:18-24.
  • [97] Magdoud K., Granados Herbepin V., Messaoudi S. Genetic variation in TGF-β1 gene and risk of idiopathic recurrent pregnancy loss. Mol Hum Reprod. 2013;19:438-443.
  • [98] Nabrdalik K., Gumprecht J., Adamczyk P., Górczyńska-Kosiorz S., Zywiec J., Grzeszczak W. Association of rs1800471 polymorphism of TGF-β1 gene with chronic kidney disease occurrence and progression and hypertension appearance. Arch Med Sci. 2013;9:230-237.
  • [99] Yuan X., Liao Z., Liu Z. Single nucleotide polymorphism at rs1982073:T869C of the TGF-β1 gene is associated with the risk of radiation pneumonitis in patients with non-small-cell lung cancer treated with definitive radiotherapy. J Clin Oncol. 2009;27:3370-3378.
  • [100] Sánchez-Parada M.G., Alvarez-Rodríguez B.A., Gómez-Meda B.C. Association of genetic polymorphisms with histological grading of necroinflammation, staging of fibrosis, and liver function in Mexicans with chronic hepatitis C virus infection. J Investig Med. 2013;61:1088-1096.
  • [101] Rashidi-Nezhad A., Azimi C., Alimoghaddam K. TGF-Beta codon 25 polymorphism and the risk of graft--host disease after allogenic hematopoietic stem cell transplantation. Iran J Allergy Asthma Immunol. 2010;9:1-6. versus
  • [102] Sommen M., Van Camp G., Liktor B. Genetic association analysis in a clinically and histologically confirmed otosclerosis population confirms association with the TGF-β1 gene but suggests an association of the RELN gene with a clinically indistinguishable otosclerosis-like phenotype. Otol Neurotol. 2014;35:1058-1064.